BNP Paribas Bonus Zert MRK 30.12..../ DE000PN8G3V1 /
5/28/2024 3:20:43 PM | Chg.+0.100 | Bid3:29:57 PM | Ask3:29:57 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
202.180EUR | +0.05% | 202.170 Bid Size: 2,000 |
202.220 Ask Size: 2,000 |
MERCK KGAA O.N. | - EUR | 12/30/2024 | Call |
GlobeNewswire
1:30 PM
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
9:00 AM
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA